---
title: Comprehensive Health Report — Version 1
---

<style>
/* Google Fonts - Inter (N1 Brand Font) */
@import url('https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap');

/* PDF Page Layout with Headers/Footers (WeasyPrint @page margin boxes) */
@page {
  size: A4;
  margin: 2.5cm 2cm;
  font-family: 'Inter', sans-serif;
  font-size: 8pt;
  color: #64748B;

  @top-center {
    content: "Comprehensive Health Report";
    font-size: 9pt;
    border-bottom: 1px solid #e5e7eb;
    padding-bottom: 8pt;
  }

  @bottom-left {
    content: "n1.care";
    color: #94a3b8;
  }

  @bottom-right {
    content: "Page " counter(page) " of " counter(pages);
    font-weight: 500;
  }
}

/* Suppress header/footer on cover page */
@page :first {
  @top-center { content: none; }
  @bottom-left { content: none; }
  @bottom-right { content: none; }
}

/* CSS Variables - N1 Brand Colors */
:root {
  --brand: #0F766E;
  --brand-dark: #134B50;
  --brand-bg: #E6F4F3;
  --success: #22C55D;
  --success-bg: #ECFDF5;
  --warning: #F59E0C;
  --warning-bg: #FEF3C7;
  --danger: #EF4444;
  --danger-bg: #FEF2F2;
  --neutral: #64748B;
  --neutral-bg: #F1F5F9;
}

/* Base Typography */
body {
  font-family: 'Inter', system-ui, -apple-system, BlinkMacSystemFont, sans-serif;
  font-size: 11pt;
  line-height: 1.6;
  color: #1a1a1a;
  margin: 0;
  padding: 0;
}

h1, h2, h3, h4 {
  color: #134B50;
  font-weight: 600;
  margin-top: 0;
}

h1 { font-size: 24pt; margin-bottom: 16px; }
h2 {
  font-size: 16pt;
  margin-top: 32px;
  padding-bottom: 8px;
  color: #0F766E;
}
h3 { font-size: 13pt; color: #0F766E; margin-top: 24px; }

/* Links */
a { color: #0F766E; text-decoration: none; }
a:hover { text-decoration: underline; }

/* Text Formatting */
strong { font-weight: 700; }
em { font-style: italic; }

/* Tables - N1 Brand Styled */
table {
  width: 100%;
  border-collapse: collapse;
  margin: 16px 0;
  font-size: 10pt;
}
thead {
  background: #0F766E;
}
th {
  background: #0F766E;
  color: white;
  font-weight: 600;
  padding: 12px 10px;
  text-align: left;
  border: none;
}
td {
  padding: 10px;
  border-bottom: 1px solid #e5e7eb;
  vertical-align: top;
}
tr:nth-child(even) td { background: #f9fafb; }
tbody tr:hover td { background: #E6F4F3; }

/* Callout Boxes */
.callout {
  border-left: 4px solid;
  border-radius: 4px;
  padding: 16px 20px;
  margin: 16px 0;
  page-break-inside: avoid;
}
.callout-brand { border-color: #0F766E; background: #E6F4F3; }
.callout-success { border-color: #22C55D; background: #ECFDF5; }
.callout-warning { border-color: #F59E0C; background: #FEF3C7; }
.callout-danger { border-color: #EF4444; background: #FEF2F2; }
.callout-neutral { border-color: #64748B; background: #F1F5F9; }
.callout-title {
  font-weight: 600;
  margin-bottom: 8px;
  font-size: 12pt;
}
.callout-brand .callout-title { color: #0F766E; }
.callout-success .callout-title { color: #22C55D; }
.callout-warning .callout-title { color: #F59E0C; }
.callout-danger .callout-title { color: #EF4444; }
.callout-neutral .callout-title { color: #64748B; }

/* Page Breaks */
.page-break { page-break-before: always; break-before: page; }
.page-break-after { page-break-after: always; break-after: page; }
.no-break { page-break-inside: avoid; break-inside: avoid; }

/* Charts */
.chart-container {
  text-align: center;
  margin: 20px 0;
  page-break-inside: avoid;
}
.chart-img {
  max-width: 100%;
  height: auto;
  page-break-inside: avoid;
}
.chart-caption {
  font-size: 10pt;
  color: #64748B;
  font-style: italic;
  margin-top: 8px;
}

/* LLM-Generated Summaries */
.chapter-summary {
  margin-bottom: 20px;
  font-size: 11pt;
  line-height: 1.6;
  color: #1e293b;
}
.chart-summary {
  margin: 8px 0 16px 0;
  padding: 12px 16px;
  background: #f8fafc;
  border-radius: 4px;
  font-size: 10pt;
  line-height: 1.4;
  color: #475569;
  page-break-inside: avoid;
}
.chart-summary p { margin: 0; }
.chart-summary ul { margin: 0; padding-left: 20px; }
.chart-summary li { margin: 2px 0; }
.chart-summary strong { color: #1e293b; display: block; margin-top: 10px; }
.chart-summary p:first-child strong { margin-top: 0; }

/* Chart Summary Links - Colored and prominent for research citations */
.chart-summary a {
  color: #2563EB;
  text-decoration: underline;
  font-weight: 500;
}
.chart-summary a:hover {
  color: #1D4ED8;
  text-decoration: underline;
}

/* Conclusion - larger, bold, color-coded */
.conclusion {
  font-size: 12pt;
  font-weight: 700;
  margin-top: 12px !important;
}
.conclusion-neutral { background: #FBBF24; color: #d97706; padding: 8px 12px; border-radius: 4px; }
.conclusion-positive { background: #92CCB7; color: #16a34a; padding: 8px 12px; border-radius: 4px; }
.conclusion-negative { background: #F87171; color: #dc2626; padding: 8px 12px; border-radius: 4px; }

.chart-block {
    page-break-inside: avoid;
    break-inside: avoid;
    margin-bottom: 1rem;
}
.chart-block strong {
    display: block;
    margin-bottom: 12px;
}


/* Front Page */
.front-page {
  text-align: center;
  padding-top: 35%;
  min-height: 90vh;
  background: white;
}
.front-page img {
  background: white;
}
.front-page-logo {
  max-width: 200px;
  margin-bottom: 40px;
}
.front-page h1 {
  font-size: 28pt;
  color: #0F766E;
  margin-bottom: 16px;
  border: none;
}
.front-page .subtitle {
  font-size: 14pt;
  color: #64748B;
  margin-bottom: 8px;
}
.front-page .date {
  font-size: 12pt;
  color: #64748B;
  margin-top: 24px;
}

/* Summary Box (for abnormal biomarkers) */
.summary-box {
  background: linear-gradient(135deg, #E6F4F3 0%, #ffffff 100%);
  border: 1px solid #0F766E;
  border-radius: 8px;
  padding: 24px;
  margin: 24px 0;
  page-break-inside: avoid;
}
.summary-box h2 {
  margin-top: 0;
  border-bottom: none;
  color: #0F766E;
}

/* Table of Contents - Brand styled per LaTeX guide */
.toc {
  background: linear-gradient(135deg, #E6F4F3 0%, #ffffff 100%);
  border: 1px solid #0F766E;
  border-radius: 8px;
  padding: 20px 24px;
  margin: 24px 0;
}
.toc h2 {
  margin-top: 0;
  border-bottom: 2px solid #0F766E;
  padding-bottom: 10px;
  color: #0F766E;
  font-size: 14pt;
}
.toc ul {
  list-style: none;
  padding-left: 0;
  margin: 0;
}
.toc li {
  padding: 6px 0;
  border-bottom: 1px solid #e5e7eb;
}
.toc li:last-child {
  border-bottom: none;
}
.toc a {
  color: #0F766E;
  font-weight: 500;
}
/* TOC Subsections - Pill/Tag Layout */
.toc-subsections {
  display: flex;
  flex-wrap: wrap;
  gap: 6px 8px;
  margin: 8px 0 4px 0;
  padding: 8px 12px;
  background: rgba(15, 118, 110, 0.03);
  border-radius: 6px;
}
.toc-pill {
  display: inline-flex;
  align-items: center;
  gap: 4px;
  background: #ffffff;
  border: 1px solid #e2e8f0;
  border-radius: 16px;
  padding: 4px 10px;
  font-size: 9pt;
  color: #64748B;
  white-space: nowrap;
}
.toc-pill a {
  color: #0F766E;
  font-weight: 400;
  text-decoration: none;
}
.toc-pill .pill-icon {
  font-size: 8pt;
  opacity: 0.7;
}
/* TOC Pills - Color coded by conclusion sentiment (text color only) */
.toc-pill.toc-pill-positive a { color: #22C55D; }
.toc-pill.toc-pill-neutral a { color: #F59E0C; }
.toc-pill.toc-pill-negative a { color: #EF4444; }

/* Pattern Charts - Flex container for biomarker pills */
.pattern-charts {
  display: flex;
  flex-wrap: wrap;
  gap: 8px;
  margin-top: 8px;
}
/* Pattern chart pills - add background for visibility */
.pattern-charts .toc-pill-positive {
  border-color: var(--success);
  background: var(--success-bg);
}
.pattern-charts .toc-pill-neutral {
  border-color: var(--warning);
  background: var(--warning-bg);
}
.pattern-charts .toc-pill-negative {
  border-color: var(--danger);
  background: var(--danger-bg);
}

/* Key Patterns & Insights Section */
.key-patterns {
  margin: 24px 0;
}
.key-patterns h2 {
  margin-top: 0;
  margin-bottom: 16px;
}

/* Category-specific patterns (under each health area header) */
.category-patterns {
  margin: 0 0 20px 0;
  padding-bottom: 16px;
  border-bottom: 1px solid #e2e8f0;
}
.category-patterns .pattern-card {
  margin-bottom: 16px;
}
.category-patterns .healthy-patterns-section {
  margin-top: 16px;
  padding-top: 12px;
}
.category-patterns .healthy-patterns-header {
  font-size: 11pt;
}

/* Pattern Card */
.pattern-card {
  margin-bottom: 24px;
  page-break-inside: avoid;
  break-inside: avoid;
}
.pattern-header {
  display: flex;
  align-items: center;
  justify-content: space-between;
  padding: 8px 0;
  margin-bottom: 8px;
}
.pattern-title {
  font-size: 12pt;
  font-weight: 600;
  color: #1e293b;
  margin: 0;
}
/* Pattern title colors based on priority (same as chart conclusions) */
.pattern-title.pattern-title-positive { color: #22C55D; }
.pattern-title.pattern-title-neutral { color: #F59E0C; }
.pattern-title.pattern-title-negative { color: #EF4444; }
.pattern-title.pattern-title-healthy { color: #22C55D; }
/* Healthy patterns section */
.healthy-patterns-section {
  margin-top: 24px;
  padding-top: 16px;
  border-top: 1px solid #e2e8f0;
}
.healthy-patterns-header {
  font-size: 12pt;
  font-weight: 600;
  color: #22C55D;
  margin: 0 0 12px 0;
}
.pattern-body {
  padding: 12px 16px;
}
.pattern-section {
  margin-bottom: 10px;
}
.pattern-section:last-child {
  margin-bottom: 0;
}
.pattern-section-title {
  font-size: 9pt;
  font-weight: 600;
  color: #64748B;
  margin-bottom: 4px;
  text-transform: uppercase;
  letter-spacing: 0.5px;
}
.pattern-section p {
  margin: 0;
  font-size: 10pt;
  line-height: 1.5;
  color: #1e293b;
}
/* Pattern description - normal black text like chart summaries */
.pattern-description {
  font-size: 10pt;
  line-height: 1.5;
  color: #1a1a1a;
  margin: 0 0 12px 0;
}
.pattern-description strong {
  font-weight: 700;
  color: #1a1a1a;
}
.pattern-section ul {
  margin: 0;
  padding-left: 16px;
  font-size: 10pt;
  line-height: 1.4;
}
.pattern-section li {
  margin-bottom: 2px;
  color: #1a1a1a;
}
/* Action section for concern patterns */
.pattern-action {
  margin-top: 12px;
  padding-top: 12px;
  border-top: 1px solid #e2e8f0;
}
.action-category {
  margin-bottom: 8px;
}
.action-category:last-child {
  margin-bottom: 0;
}
.action-label {
  font-size: 9pt;
  font-weight: 600;
  color: #0F766E;
  display: block;
  margin-bottom: 2px;
}
.action-category ul {
  margin: 0;
  padding-left: 16px;
  font-size: 10pt;
  line-height: 1.4;
}
.action-category li {
  margin-bottom: 2px;
  color: #1a1a1a;
}

/* Direction indicators for biomarker values */
.direction-high { color: var(--danger); font-weight: 500; }
.direction-low { color: #2563EB; font-weight: 500; }
.direction-normal { color: var(--success); }

/* Report Settings - Compact to fit single page */
.settings-section {
  background: #F1F5F9;
  border-radius: 8px;
  padding: 12px 20px;
  margin-top: 16px;
  font-size: 10pt;
}
.settings-section h2 {
  margin-top: 0;
  font-size: 14pt;
  border-bottom: none;
}
.settings-section h3 {
  font-size: 11pt;
  margin-top: 12px;
  margin-bottom: 6px;
}
.settings-section table {
  margin: 8px 0;
}
.settings-section td {
  padding: 4px 8px;
}
.settings-section p {
  margin: 4px 0;
}

/* Horizontal Rule */
hr {
  border: none;
  border-top: 1px solid #e5e7eb;
  margin: 24px 0;
}

/* Lists */
ul, ol {
  padding-left: 24px;
}
li {
  margin-bottom: 6px;
}
</style>

<div class="toc">

## Table of Contents

- [Key Patterns & Insights](#key-patterns)
- [Hematologic (Blood Health)](#cat-hematologic-blood-health) *(13 charts)*
<div class="toc-subsections">
<span class="toc-pill toc-pill-neutral"><span class="pill-icon">📊</span><a href="#chart-5442c1d5-6e55-4763-8cfc-0fae78a6a9f7">White Blood Cell Count [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-9486cf79-eba6-4a98-8214-b01ffe687e19">Hemoglobin [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-f17aba9b-fca2-4c06-a22d-9efd19155dc2">Monocyte Percentage [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-f304ae81-c33a-4f26-bc75-a7f5e5b1e85a">Neutrophil Absolute Count [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-31570e84-876f-4846-9699-8b650b028fbb">Neutrophil Percentage [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-7baeed38-a16e-405f-92c3-f42df664c6e8">Lymphocyte Percentage [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-d17bba20-80bb-420f-95df-5dbd18ad37f2">Mean Corpuscular Hemoglobin Concentration [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-213fa6f3-a17f-4e51-a175-fab8f914eb63">Platelet Count [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-neutral"><span class="pill-icon">📊</span><a href="#chart-c8be8a96-b1d0-48f6-8197-c2f6d816bb19">Red Blood Cell Count [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-negative"><span class="pill-icon">📊</span><a href="#chart-16005026-de62-40ff-8a69-ae4d827204ac">Basophil Percentage [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-b6e1c148-73de-48d6-ad3e-469add392171">Lymphocyte Absolute Count [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-5e36d8b9-62d5-4dfc-bdf6-a95d3fc39a9d">Red Cell Distribution Width [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-neutral"><span class="pill-icon">📊</span><a href="#chart-8d7c03d6-664b-485b-b73c-714c5ca2cfa5">Eosinophil Percentage [In Blood - Quantitative]</a></span>
</div>

- [Cardiovascular](#cat-cardiovascular) *(4 charts)*
<div class="toc-subsections">
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-1931b4e7-5f08-4619-8727-d832b70b7014">Systolic Blood Pressure</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-3ee16365-2ef7-44f9-b27c-95d88d6539bd">Pulse Rate</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-3ee16365-2ef7-44f9-b27c-95d88d6539bd">Pulse Rate</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-506b12d1-0a67-49b1-97a7-7c5dffb4f7e1">Diastolic Blood Pressure</a></span>
</div>

- [Other/Not categorisable](#cat-other-not-categorisable) *(3 charts)*
<div class="toc-subsections">
<span class="toc-pill toc-pill-neutral"><span class="pill-icon">📊</span><a href="#chart-79ab4e7c-3afb-40df-a48f-e50e3cfc5e04">Omicm Age</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-fbf25ee8-ac60-4416-9c29-615fcbf38fcd">Alkaline Phosphatase [In Serum - Quantitative]</a></span>
<span class="toc-pill toc-pill-negative"><span class="pill-icon">📊</span><a href="#chart-67cd9fc2-def8-43ed-9aac-f727967a8161">Hemoglobin A1C [In Blood - Quantitative]</a></span>
</div>

- [Report Settings](#report-settings)

</div>

<div class="page-break"></div>

<a id="key-patterns"></a>
<div class="key-patterns">
<h2>Key Patterns & Insights</h2>
<div class="pattern-card">
<div class="pattern-header">
<h3 class="pattern-title pattern-title-negative">Cardiometabolic Risk Cluster</h3>
</div>
<div class="pattern-body">
<p class="pattern-description">Borderline-elevated blood pressures coupled with a top-of-normal Hemoglobin A1c indicate <strong>early cardiometabolic strain</strong> across vascular and glucose-regulating systems.</p>
<div class="pattern-section">
<div class="pattern-section-title">Connected Charts</div>
<div class="pattern-charts">
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-1931b4e7-5f08-4619-8727-d832b70b7014">Systolic Blood Pressure</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-506b12d1-0a67-49b1-97a7-7c5dffb4f7e1">Diastolic Blood Pressure</a></span>
<span class="toc-pill toc-pill-negative"><span class="pill-icon">📊</span><a href="#chart-67cd9fc2-def8-43ed-9aac-f727967a8161">Hemoglobin A1C [In Blood - Quantitative]</a></span>
</div>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Causes</div>
<ul>
<li>Developing insulin resistance or metabolic syndrome</li>
<li>High dietary sodium, stress or low physical activity</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Effects</div>
<ul>
<li>Progression to sustained hypertension and type 2 diabetes</li>
<li>Increased long-term cardiovascular and renal risk</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Possible Actions</div>
<ul>
<li>Initiate lifestyle counseling on diet, weight and exercise</li>
<li>Home blood-pressure and HbA1c re-check within 3–6 months</li>
<li>Consider cardiovascular risk scoring to guide intensity of intervention</li>
</ul>
</div>
</div>
</div>
<div class="pattern-card">
<div class="pattern-header">
<h3 class="pattern-title pattern-title-neutral">Subclinical Multi-line Cytopenia</h3>
</div>
<div class="pattern-body">
<p class="pattern-description">Slightly low Red Blood Cell Count with low-normal Platelet and White Blood Cell metrics suggests <strong>early or mild bone-marrow or nutrient compromise</strong>.</p>
<div class="pattern-section">
<div class="pattern-section-title">Connected Charts</div>
<div class="pattern-charts">
<span class="toc-pill toc-pill-neutral"><span class="pill-icon">📊</span><a href="#chart-c8be8a96-b1d0-48f6-8197-c2f6d816bb19">Red Blood Cell Count [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-negative"><span class="pill-icon">📊</span><a href="#chart-67cd9fc2-def8-43ed-9aac-f727967a8161">Hemoglobin A1C [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-213fa6f3-a17f-4e51-a175-fab8f914eb63">Platelet Count [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-neutral"><span class="pill-icon">📊</span><a href="#chart-5442c1d5-6e55-4763-8cfc-0fae78a6a9f7">White Blood Cell Count [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-f304ae81-c33a-4f26-bc75-a7f5e5b1e85a">Neutrophil Absolute Count [In Blood - Quantitative]</a></span>
</div>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Causes</div>
<ul>
<li>Iron, B12 or folate deficiency</li>
<li>Early bone-marrow suppression (medication, viral, autoimmune)</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Effects</div>
<ul>
<li>Progressive anemia, fatigue and reduced exercise tolerance</li>
<li>Lower reserve against infection or bleeding</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Possible Actions</div>
<ul>
<li>Order iron studies, B12/folate levels and reticulocyte count</li>
<li>Review medication/toxin exposure; monitor complete blood count serially</li>
</ul>
</div>
</div>
</div>
<div class="pattern-card">
<div class="pattern-header">
<h3 class="pattern-title pattern-title-neutral">Bradycardia with Elevated Diastolic Pressure</h3>
</div>
<div class="pattern-body">
<p class="pattern-description">Resting Pulse Rate of 51 bpm co-exists with borderline-high Diastolic Blood Pressure, hinting at <strong>possible autonomic imbalance or medication effect</strong> rather than pure athletic adaptation.</p>
<div class="pattern-section">
<div class="pattern-section-title">Connected Charts</div>
<div class="pattern-charts">
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-3ee16365-2ef7-44f9-b27c-95d88d6539bd">Pulse Rate</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-506b12d1-0a67-49b1-97a7-7c5dffb4f7e1">Diastolic Blood Pressure</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-1931b4e7-5f08-4619-8727-d832b70b7014">Systolic Blood Pressure</a></span>
</div>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Causes</div>
<ul>
<li>Beta-blocker or other rate-limiting therapy</li>
<li>High vagal tone with concurrent vascular stiffness</li>
<li>Thyroid or conduction system disorders</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Effects</div>
<ul>
<li>Syncope, fatigue if rate drops further</li>
<li>Masking of worsening hypertension</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Possible Actions</div>
<ul>
<li>Review medication list and symptom history</li>
<li>Consider ECG and thyroid evaluation</li>
<li>Ambulatory blood-pressure and heart-rate monitoring</li>
</ul>
</div>
</div>
</div>
<div class="healthy-patterns-section">
<h3 class="healthy-patterns-header">Healthy Patterns</h3>
<div class="pattern-card">
<div class="pattern-header">
<h3 class="pattern-title pattern-title-healthy">Well-Balanced Immune Differential</h3>
</div>
<div class="pattern-body">
<p class="pattern-description">Normal White Blood Cell Count with proportionate differential percentages indicates <strong>balanced immune and inflammatory status</strong>.</p>
<div class="pattern-section">
<div class="pattern-section-title">Connected Charts</div>
<div class="pattern-charts">
<span class="toc-pill toc-pill-neutral"><span class="pill-icon">📊</span><a href="#chart-5442c1d5-6e55-4763-8cfc-0fae78a6a9f7">White Blood Cell Count [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-31570e84-876f-4846-9699-8b650b028fbb">Neutrophil Percentage [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-7baeed38-a16e-405f-92c3-f42df664c6e8">Lymphocyte Percentage [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-f17aba9b-fca2-4c06-a22d-9efd19155dc2">Monocyte Percentage [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-neutral"><span class="pill-icon">📊</span><a href="#chart-8d7c03d6-664b-485b-b73c-714c5ca2cfa5">Eosinophil Percentage [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-negative"><span class="pill-icon">📊</span><a href="#chart-16005026-de62-40ff-8a69-ae4d827204ac">Basophil Percentage [In Blood - Quantitative]</a></span>
</div>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Causes</div>
<ul>
<li>Adequate micronutrient status</li>
<li>Absence of active infection or systemic inflammation</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Effects</div>
<ul>
<li>Reduced risk of infection complications</li>
<li>Lower chronic inflammatory burden</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Possible Actions</div>
<ul>
<li>Maintain current lifestyle and nutrition habits</li>
</ul>
</div>
</div>
</div>
<div class="pattern-card">
<div class="pattern-header">
<h3 class="pattern-title pattern-title-healthy">Preserved Hepatic–Bone Enzyme Status</h3>
</div>
<div class="pattern-body">
<p class="pattern-description">Alkaline Phosphatase sits comfortably mid-range, supporting <strong>healthy liver and bone turnover</strong>.</p>
<div class="pattern-section">
<div class="pattern-section-title">Connected Charts</div>
<div class="pattern-charts">
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-fbf25ee8-ac60-4416-9c29-615fcbf38fcd">Alkaline Phosphatase [In Serum - Quantitative]</a></span>
</div>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Causes</div>
<ul>
<li>Adequate vitamin D and mineral balance</li>
<li>Absence of cholestasis or bone disease</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Effects</div>
<ul>
<li>Lower risk of hepatic or skeletal pathology</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Possible Actions</div>
<ul>
<li>Continue weight-bearing exercise and balanced nutrition</li>
</ul>
</div>
</div>
</div>
<div class="pattern-card">
<div class="pattern-header">
<h3 class="pattern-title pattern-title-healthy">Stable Red-Cell Morphology</h3>
</div>
<div class="pattern-body">
<p class="pattern-description">Normal Mean Corpuscular Hemoglobin Concentration and Red Cell Distribution Width demonstrate <strong>uniform, well-hemoglobinized erythrocytes</strong>.</p>
<div class="pattern-section">
<div class="pattern-section-title">Connected Charts</div>
<div class="pattern-charts">
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-d17bba20-80bb-420f-95df-5dbd18ad37f2">Mean Corpuscular Hemoglobin Concentration [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-5e36d8b9-62d5-4dfc-bdf6-a95d3fc39a9d">Red Cell Distribution Width [In Blood - Quantitative]</a></span>
</div>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Causes</div>
<ul>
<li>Sufficient iron incorporation into red cells</li>
<li>Lack of significant anisocytosis or hemoglobinopathy</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Effects</div>
<ul>
<li>Efficient oxygen transport capacity</li>
<li>Lower likelihood of micro- or macrocytic anemia forms</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Possible Actions</div>
<ul>
<li>Re-evaluate only if Red Blood Cell Count declines further</li>
</ul>
</div>
</div>
</div>
</div>
</div>

<div class="page-break"></div>

<a id="cat-hematologic-blood-health"></a>

## Hematologic (Blood Health)

<div class="category-patterns">
<div class="pattern-card">
<div class="pattern-header">
<h3 class="pattern-title pattern-title-neutral">Mild Pancytopenic Trend</h3>
</div>
<div class="pattern-body">
<p class="pattern-description">Red Blood Cell Count is below reference while Platelet Count and White Blood Cell Count sit at the low-normal edge, suggesting <strong>early or mild global marrow under-production</strong> rather than an isolated cytopenia.</p>
<div class="pattern-section">
<div class="pattern-section-title">Connected Charts</div>
<div class="pattern-charts">
<span class="toc-pill toc-pill-neutral"><span class="pill-icon">📊</span><a href="#chart-c8be8a96-b1d0-48f6-8197-c2f6d816bb19">Red Blood Cell Count [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-213fa6f3-a17f-4e51-a175-fab8f914eb63">Platelet Count [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-neutral"><span class="pill-icon">📊</span><a href="#chart-5442c1d5-6e55-4763-8cfc-0fae78a6a9f7">White Blood Cell Count [In Blood - Quantitative]</a></span>
</div>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Causes</div>
<ul>
<li>Subclinical nutritional deficiency (iron, B12, folate)</li>
<li>Early bone marrow suppression (medications, viral illness, chronic disease)</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Effects</div>
<ul>
<li>Progression to overt anemia, thrombocytopenia, or leukopenia</li>
<li>Fatigue, bleeding tendency, increased infection risk if deterioration continues</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Possible Actions</div>
<ul>
<li>Repeat complete blood count in 4–6 weeks</li>
<li>Assess iron studies, vitamin B12, folate, and review current medications or toxins</li>
</ul>
</div>
</div>
</div>
<div class="pattern-card">
<div class="pattern-header">
<h3 class="pattern-title pattern-title-positive">Borderline Neutropenia with Relative Lymphocytosis</h3>
</div>
<div class="pattern-body">
<p class="pattern-description">Neutrophil Absolute Count hovers just above the lower limit while Lymphocyte Percentage is high-normal, yielding a low neutrophil-to-lymphocyte balance that could herald <strong>early neutropenia or recent viral immune shift</strong>.</p>
<div class="pattern-section">
<div class="pattern-section-title">Connected Charts</div>
<div class="pattern-charts">
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-f304ae81-c33a-4f26-bc75-a7f5e5b1e85a">Neutrophil Absolute Count [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-7baeed38-a16e-405f-92c3-f42df664c6e8">Lymphocyte Percentage [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-31570e84-876f-4846-9699-8b650b028fbb">Neutrophil Percentage [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-neutral"><span class="pill-icon">📊</span><a href="#chart-5442c1d5-6e55-4763-8cfc-0fae78a6a9f7">White Blood Cell Count [In Blood - Quantitative]</a></span>
</div>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Causes</div>
<ul>
<li>Recent viral infection</li>
<li>Drug-related marrow suppression</li>
<li>Benign ethnic neutropenia</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Effects</div>
<ul>
<li>Reduced first-line bacterial defense if neutrophils fall further</li>
<li>Need for monitoring during intercurrent illness</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Possible Actions</div>
<ul>
<li>Monitor Absolute Neutrophil Count on follow-up</li>
<li>Review recent infections and medication history</li>
</ul>
</div>
</div>
</div>
<div class="healthy-patterns-section">
<h4 class="healthy-patterns-header">Healthy Patterns</h4>
<div class="pattern-card">
<div class="pattern-header">
<h3 class="pattern-title pattern-title-healthy">Stable Erythrocyte Indices</h3>
</div>
<div class="pattern-body">
<p class="pattern-description">Hemoglobin, Mean Corpuscular Hemoglobin Concentration, and Red Cell Distribution Width all sit comfortably in range, indicating <strong>well-maintained erythrocyte size and hemoglobinization without iron-deficiency or macrocytic changes</strong>.</p>
<div class="pattern-section">
<div class="pattern-section-title">Connected Charts</div>
<div class="pattern-charts">
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-9486cf79-eba6-4a98-8214-b01ffe687e19">Hemoglobin [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-d17bba20-80bb-420f-95df-5dbd18ad37f2">Mean Corpuscular Hemoglobin Concentration [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-5e36d8b9-62d5-4dfc-bdf6-a95d3fc39a9d">Red Cell Distribution Width [In Blood - Quantitative]</a></span>
</div>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Causes</div>
<ul>
<li>Adequate iron and vitamin status</li>
<li>Absence of active hemolysis or marrow stress</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Effects</div>
<ul>
<li>Sustained oxygen-carrying capacity</li>
<li>Lower cardiovascular and fatigue risk</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Possible Actions</div>
<ul>
<li>Continue balanced nutrition and routine surveillance</li>
</ul>
</div>
</div>
</div>
</div>
</div>

<div class="page-break"></div>

<a id="cat-hematologic-blood-health-charts"></a>

<div class="chart-block">
<a id="chart-5442c1d5-6e55-4763-8cfc-0fae78a6a9f7"></a>
<strong>White Blood Cell Count [In Blood - Quantitative]</strong>

<img src="charts/5442c1d5-6e55-4763-8cfc-0fae78a6a9f7.png" alt="White Blood Cell Count [in Blood - Quantitative]" style="width: 450px; height: 225px; page-break-inside: avoid;" />

<p class="conclusion conclusion-neutral">Counts oscillate around lower reference limit with intermittent lows; further evaluation warranted.</p>

<div class="chart-summary"><p><strong>Description</strong></p>
<p>Blood leukocyte count reflecting immune cell quantity.</p>
<p><strong>Measurements</strong></p>
<p>Trend: Flat – fluctuating low counts with occasional spikes, recent values low-normal</p>
<ul>
<li>Apr 2024: 6.1 ×10⁹/L</li>
<li>May 2024: 3.4 ×10⁹/L</li>
<li>Sep 2024: 3.1 ×10⁹/L</li>
<li>Oct 2024: 4.1 ×10⁹/L</li>
<li>Nov 2024: 4.6 ×10⁹/L</li>
<li>Dec 2024: 4.2 ×10⁹/L</li>
<li>Feb 2025: avg 18.8 (2 readings)</li>
<li>Mar 2025: 5.9 ×10⁹/L</li>
<li>May 2025: 3.8 ×10⁹/L</li>
<li>Jun 2025: 3.7 ×10⁹/L</li>
<li>Jun 2025: 13.6 (unit unclear)</li>
<li>Aug 2025: 10 (arbitrary units)</li>
<li>Sep 2025: 4.2 ×10⁹/L</li>
<li>Oct 2025: 3.72 ×10⁹/L</li>
<li>Oct 2025: 4.6 ×10⁹/L</li>
<li>Nov 2025: 4.4 ×10⁹/L</li>
</ul>
<p><strong>Clinical meaning</strong></p>
<ul>
<li>Recurrent leukopenia episodes suggest possible marrow, medication, or infection influence.</li>
<li>Sporadic elevations may reflect stress response or unit variation.</li>
</ul>
<p><strong>Action</strong></p>
<p>Evaluate causes of intermittent leukopenia with differential count and clinical correlation.</p>
<p><strong>Sample source</strong></p>
<p>Blood</p></div>

</div>

<div class="page-break"></div>

<div class="chart-block">
<a id="chart-9486cf79-eba6-4a98-8214-b01ffe687e19"></a>
<strong>Hemoglobin [In Blood - Quantitative]</strong>

<img src="charts/9486cf79-eba6-4a98-8214-b01ffe687e19.png" alt="Hemoglobin [in Blood - Quantitative]" style="width: 450px; height: 225px; page-break-inside: avoid;" />

<p class="conclusion conclusion-positive">Hemoglobin stable, normal range; transient low value no longer present.</p>

<div class="chart-summary"><p><strong>Description</strong></p>
<p>Oxygen-carrying protein concentration in blood</p>
<p><strong>Measurements</strong></p>
<p>Trend: Flat – stable mid-14 g/dL; single January dip recovered</p>
<ul>
<li>Apr 2024: 14.9 g/dL</li>
<li>Sep 2024: 14.6 g/dL</li>
<li>Oct 2024: 14.2 g/dL</li>
<li>Nov 2024: 14.5 g/dL</li>
<li>Dec 2024: 15.7 g/dL</li>
<li>Jan 2025: 11.65 (low)</li>
<li>Mar 2025: avg 14.55 g/dL (2 readings)</li>
<li>May 2025: 14.4 g/dL</li>
<li>Jun 2025: avg 11.35 (2 readings, mixed units)</li>
<li>Jul 2025: 14.5 g/dL</li>
<li>Sep 2025: 14.8 g/dL</li>
<li>Oct 2025: avg 14.55 g/dL (2 readings)</li>
<li>Nov 2025: 13.7 g/dL</li>
</ul>
<p><strong>Clinical meaning</strong></p>
<ul>
<li>Current values sit within reference range, indicating adequate oxygen-carrying capacity</li>
<li>Brief January anemia episode resolved without persistent deficit</li>
</ul>
<p><strong>Action</strong></p>
<p>No action required</p>
<p><strong>Sample source</strong></p>
<p>Blood</p></div>

</div>

<div class="page-break"></div>

<div class="chart-block">
<a id="chart-f17aba9b-fca2-4c06-a22d-9efd19155dc2"></a>
<strong>Monocyte Percentage [In Blood - Quantitative]</strong>

<img src="charts/f17aba9b-fca2-4c06-a22d-9efd19155dc2.png" alt="Monocyte Percentage [in Blood - Quantitative]" style="width: 450px; height: 225px; page-break-inside: avoid;" />

<p class="conclusion conclusion-positive">Monocyte percentage stable within normal limits after transient 2024 peak.</p>

<div class="chart-summary"><p><strong>Description</strong></p>
<p>White blood cell subset indicating innate immune activity</p>
<p><strong>Measurements</strong></p>
<p>Trend: Falling slightly – peak Sep 2024 then gradual return to mid-range</p>
<ul>
<li>Apr 2024: 3.9%</li>
<li>May 2024: 9.0%</li>
<li>Jul 2024: 6.8%</li>
<li>Sep 2024: 12.9%</li>
<li>Oct 2024: 6.0%</li>
<li>Nov 2024: 7.8%</li>
<li>Dec 2024: 6.6%</li>
<li>Jan 2025: 10.1%</li>
<li>Mar 2025: 5.6%</li>
<li>May 2025: avg 7.2% (2 readings)</li>
<li>Jun 2025: 5.4%</li>
<li>Jul 2025: 6.7%</li>
<li>Sep 2025: 5.0%</li>
<li>Oct 2025: avg 5.0% (2 readings)</li>
<li>Nov 2025: 7.2%</li>
</ul>
<p><strong>Clinical meaning</strong></p>
<ul>
<li>Values now sit comfortably within reference range</li>
<li>Prior brief spikes likely reactive, no persistent elevation observed</li>
</ul>
<p><strong>Action</strong></p>
<p>No action required</p>
<p><strong>Sample source</strong></p>
<p>Blood</p></div>

</div>

<div class="page-break"></div>

<div class="chart-block">
<a id="chart-f304ae81-c33a-4f26-bc75-a7f5e5b1e85a"></a>
<strong>Neutrophil Absolute Count [In Blood - Quantitative]</strong>

<img src="charts/f304ae81-c33a-4f26-bc75-a7f5e5b1e85a.png" alt="Neutrophil Absolute Count [in Blood - Quantitative]" style="width: 450px; height: 225px; page-break-inside: avoid;" />

<p class="conclusion conclusion-positive">Neutrophil count moved from low to low-normal, now steady; no immediate concern.</p>

<div class="chart-summary"><p><strong>Description</strong></p>
<p>Blood marker estimating mature granulocyte population and innate immune capacity</p>
<p><strong>Measurements</strong></p>
<p>Trend: Rising - early neutropenia corrected, now stable low-normal</p>
<ul>
<li>May 2024: 1.5 X10⁹/L</li>
<li>Sep 2024: 1.2 X10⁹/L</li>
<li>Oct 2024: 1.9 X10⁹/L</li>
<li>Nov 2024: 2.5 X10⁹/L</li>
<li>Dec 2024: 2.3 X10⁹/L</li>
<li>Feb 2025: 22.8 nan</li>
<li>Mar 2025: 3.6 X10⁹/L</li>
<li>May 2025: 2.0 X10⁹/L</li>
<li>Jun 2025: 6.4 nan</li>
<li>Jul 2025: 2.3 X10⁹/L</li>
<li>Aug 2025: 15 Arbitrary Units</li>
<li>Sep 2025: 2.3 X10⁹/L</li>
<li>Oct 2025: 2.8 X10⁹/L</li>
<li>Nov 2025: 2.1 X10⁹/L</li>
</ul>
<p><strong>Clinical meaning</strong></p>
<ul>
<li>Initial counts below 2.0 X10⁹/L suggested neutropenia with infection risk</li>
<li>Current values within reference; resilience of innate immunity improved</li>
</ul>
<p><strong>Action</strong></p>
<p>Recheck in 6 months</p>
<p><strong>Sample source</strong></p>
<p>Blood</p></div>

</div>

<div class="page-break"></div>

<div class="chart-block">
<a id="chart-31570e84-876f-4846-9699-8b650b028fbb"></a>
<strong>Neutrophil Percentage [In Blood - Quantitative]</strong>

<img src="charts/31570e84-876f-4846-9699-8b650b028fbb.png" alt="Neutrophil Percentage [in Blood - Quantitative]" style="width: 450px; height: 225px; page-break-inside: avoid;" />

<p class="conclusion conclusion-positive">Values stable within normal limits; transient lows resolved.</p>

<div class="chart-summary"><p><strong>Description</strong></p>
<p>Percentage of neutrophils among circulating white cells</p>
<p><strong>Measurements</strong></p>
<p>Trend: Flat – fluctuates but stays largely inside reference</p>
<ul>
<li>April 2024: 73.5%</li>
<li>May 2024: 45.0%</li>
<li>Sep 2024: 37.8%</li>
<li>Oct 2024: 47.0%</li>
<li>Nov 2024: 53.6%</li>
<li>Dec 2024: 54.2%</li>
<li>Jan 2025: 39.9%</li>
<li>Mar 2025: avg 65.7% (3 readings)</li>
<li>May 2025: 52.5%</li>
<li>Jul 2025: 49.0%</li>
<li>Sep 2025: 54.5%</li>
<li>Oct 2025: avg 57.4% (2 readings)</li>
<li>Nov 2025: 47.0%</li>
</ul>
<p><strong>Clinical meaning</strong></p>
<ul>
<li>Mostly normal range; brief mild neutropenia at 37.8% and 39.9%</li>
<li>No sustained inflammatory or myeloproliferative signal</li>
</ul>
<p><strong>Action</strong></p>
<p>No action required</p>
<p><strong>Sample source</strong></p>
<p>Blood</p></div>

</div>

<div class="page-break"></div>

<div class="chart-block">
<a id="chart-7baeed38-a16e-405f-92c3-f42df664c6e8"></a>
<strong>Lymphocyte Percentage [In Blood - Quantitative]</strong>

<img src="charts/7baeed38-a16e-405f-92c3-f42df664c6e8.png" alt="Lymphocyte Percentage [in Blood - Quantitative]" style="width: 450px; height: 225px; page-break-inside: avoid;" />

<p class="conclusion conclusion-positive">Lymphocyte percentage largely normal, transient elevation self-corrected</p>

<div class="chart-summary"><p><strong>Description</strong></p>
<p>White-blood-cell subtype ratio indicating immune status</p>
<p><strong>Measurements</strong></p>
<p>Trend: Rising slightly – net increase from low 22 % to 43 %, fluctuations moderate</p>
<ul>
<li>Apr 2024: 21.7 %</li>
<li>May 2024: 43.0 %</li>
<li>Sep 2024: 47.1 %</li>
<li>Oct 2024: 44.0 %</li>
<li>Nov 2024: 36.2 %</li>
<li>Dec 2024: 36.6 %</li>
<li>Mar 2025: avg 27.3 % (2 readings)</li>
<li>May 2025: 38.7 %</li>
<li>Jun 2025: 36.3 %</li>
<li>Jul 2025: 41.2 %</li>
<li>Sep 2025: 38.0 %</li>
<li>Oct 2025: avg 34.2 % (2 readings)</li>
<li>Nov 2025: 43.1 %</li>
</ul>
<p><strong>Clinical meaning</strong></p>
<ul>
<li>Most results inside 20–45 % reference; one mild high in Sep 2024 only</li>
<li>Pattern suggests stable immune cell distribution without persistent abnormality</li>
</ul>
<p><strong>Action</strong></p>
<p>No action required</p>
<p><strong>Sample source</strong></p>
<p>Blood</p></div>

</div>

<div class="page-break"></div>

<div class="chart-block">
<a id="chart-d17bba20-80bb-420f-95df-5dbd18ad37f2"></a>
<strong>Mean Corpuscular Hemoglobin Concentration [In Blood - Quantitative]</strong>

<img src="charts/d17bba20-80bb-420f-95df-5dbd18ad37f2.png" alt="Mean Corpuscular Hemoglobin Concentration [in Blood - Quantitative]" style="width: 450px; height: 225px; page-break-inside: avoid;" />

<p class="conclusion conclusion-positive">MCHC stable within normal limits; transient dip resolved.</p>

<div class="chart-summary"><p><strong>Description</strong></p>
<p>Average hemoglobin per red cell volume</p>
<p><strong>Measurements</strong></p>
<p>Trend: Flat - Values stable; brief low Oct 2025 recovered</p>
<ul>
<li>Apr 2024: 32.0 G/DL</li>
<li>May 2024: 32.9 G/DL</li>
<li>Jul 2024: 33.3 G/DL</li>
<li>Sep 2024: 33.0 G/DL</li>
<li>Oct 2024: 34.7 G/DL</li>
<li>Nov 2024: 33.0 G/DL</li>
<li>Dec 2024: 33.0 G/DL</li>
<li>Mar 2025: avg 34.0 G/DL (2 readings)</li>
<li>May 2025: 35.0 G/DL</li>
<li>Jul 2025: avg 33.0 G/DL (2 readings)</li>
<li>Sep 2025: 33.0 G/DL</li>
<li>Oct 2025: avg 30.4 G/DL (2 readings)</li>
<li>Nov 2025: 33.0 G/DL</li>
</ul>
<p><strong>Clinical meaning</strong></p>
<ul>
<li>Values within standard range; adequate cell hemoglobin concentration</li>
<li>Single low Oct 2025 reading likely transient or dilutional</li>
</ul>
<p><strong>Action</strong></p>
<p>No action required</p>
<p><strong>Sample source</strong></p>
<p>Blood</p></div>

</div>

<div class="page-break"></div>

<div class="chart-block">
<a id="chart-213fa6f3-a17f-4e51-a175-fab8f914eb63"></a>
<strong>Platelet Count [In Blood - Quantitative]</strong>

<img src="charts/213fa6f3-a17f-4e51-a175-fab8f914eb63.png" alt="Platelet Count [in Blood - Quantitative]" style="width: 450px; height: 225px; page-break-inside: avoid;" />

<p class="conclusion conclusion-positive">Platelet levels improved from mildly low to stable low-normal without concerning decline.</p>

<div class="chart-summary"><p><strong>Description</strong></p>
<p>Circulating platelet concentration indicator of clotting capacity.</p>
<p><strong>Measurements</strong></p>
<p>Trend: Rising slightly - values moved from low to low-normal</p>
<ul>
<li>Apr 2024: 146 x10⁹/L</li>
<li>May 2024: 134 x10⁹/L</li>
<li>Jul 2024: 178 x10⁹/L</li>
<li>Sep 2024: 146 x10⁹/L</li>
<li>Oct 2024: 143 x10⁹/L</li>
<li>Nov 2024: 173 x10⁹/L</li>
<li>Dec 2024: 145 x10⁹/L</li>
<li>Mar 2025: avg 171 x10⁹/L (2 readings)</li>
<li>May 2025: 168 x10⁹/L</li>
<li>Jun 2025: avg 176 x10⁹/L (2 readings)</li>
<li>Sep 2025: 174 x10⁹/L</li>
<li>Oct 2025: avg 169 x10⁹/L (2 readings)</li>
<li>Nov 2025: 157 x10⁹/L</li>
</ul>
<p><strong>Clinical meaning</strong></p>
<ul>
<li>Early mild thrombocytopenia resolved; counts now within range.</li>
<li>Low-normal values suggest adequate but borderline platelet reserve.</li>
</ul>
<p><strong>Action</strong></p>
<p>No action required.</p>
<p><strong>Sample source</strong></p>
<p>Blood</p></div>

</div>

<div class="page-break"></div>

<div class="chart-block">
<a id="chart-c8be8a96-b1d0-48f6-8197-c2f6d816bb19"></a>
<strong>Red Blood Cell Count [In Blood - Quantitative]</strong>

<img src="charts/c8be8a96-b1d0-48f6-8197-c2f6d816bb19.png" alt="Red Blood Cell Count [in Blood - Quantitative]" style="width: 450px; height: 225px; page-break-inside: avoid;" />

<p class="conclusion conclusion-neutral">RBC counts generally normal but latest low reading and downward drift merit timely follow-up.</p>

<div class="chart-summary"><p><strong>Description</strong></p>
<p>Blood measure of erythrocyte concentration, proxy for oxygen-carrying capacity.</p>
<p><strong>Measurements</strong></p>
<p>Trend: Falling slightly – values oscillate near lower limit, latest low</p>
<ul>
<li>Apr 2024: 4.80 ×10¹²/L</li>
<li>May 2024: 4.62 ×10¹²/L</li>
<li>Sep 2024: 4.80 ×10¹²/L</li>
<li>Oct 2024: 4.43 ×10¹²/L</li>
<li>Nov 2024: 4.70 ×10¹²/L</li>
<li>Dec 2024: 5.15 ×10¹²/L</li>
<li>Mar 2025: 4.50 ×10¹²/L</li>
<li>Jun 2025: avg 4.70 ×10¹²/L (2 readings)</li>
<li>Jul 2025: 4.73 ×10¹²/L</li>
<li>Sep 2025: 4.77 ×10¹²/L</li>
<li>Oct 2025: avg 4.69 ×10¹²/L (2 readings)</li>
<li>Nov 2025: 4.40 ×10¹²/L</li>
</ul>
<p><strong>Clinical meaning</strong></p>
<ul>
<li>Mostly within reference; two dips suggest intermittent borderline anemia.</li>
<li>Slight downward drift warrants surveillance if fatigue, pallor present.</li>
</ul>
<p><strong>Action</strong></p>
<p>Repeat full blood count and iron studies within 3 months.</p>
<p><strong>Sample source</strong></p>
<p>Blood</p></div>

</div>

<div class="page-break"></div>

<div class="chart-block">
<a id="chart-16005026-de62-40ff-8a69-ae4d827204ac"></a>
<strong>Basophil Percentage [In Blood - Quantitative]</strong>

<img src="charts/16005026-de62-40ff-8a69-ae4d827204ac.png" alt="Basophil Percentage [in Blood - Quantitative]" style="width: 450px; height: 225px; page-break-inside: avoid;" />

<p class="conclusion conclusion-negative">Values largely normal but isolated extreme spike needs confirmation</p>

<div class="chart-summary"><p><strong>Description</strong></p>
<p>Basophil percentage reflects circulating basophil proportion in white blood cell differential</p>
<p><strong>Measurements</strong></p>
<p>Trend: Flat - isolated Jan 2025 spike then stable within 0.0–1.1%</p>
<ul>
<li>Apr 2024: 0.4 %</li>
<li>May 2024: 1.0 %</li>
<li>Sep 2024: 0.6 %</li>
<li>Oct 2024: 1.0 %</li>
<li>Dec 2024: 0.9 %</li>
<li>Jan 2025: 32.1 %</li>
<li>Mar 2025: 0.7 %</li>
<li>May 2025: 0.8 %</li>
<li>Jun 2025: 1.1 %</li>
<li>Jul 2025: avg 0.5 % (2 readings)</li>
<li>Sep 2025: 0.0 %</li>
<li>Oct 2025: 0.8 %</li>
<li>Nov 2025: 0.9 %</li>
</ul>
<p><strong>Clinical meaning</strong></p>
<ul>
<li>Normal 0–2 % except single extreme elevation Jan 2025</li>
<li>Sustained normal levels imply minimal ongoing allergic, inflammatory, or myeloproliferative activity</li>
</ul>
<p><strong>Action</strong></p>
<p>Verify Jan 2025 spike with repeat differential</p>
<p><strong>Sample source</strong></p>
<p>Blood</p></div>

</div>

<div class="page-break"></div>

<div class="chart-block">
<a id="chart-b6e1c148-73de-48d6-ad3e-469add392171"></a>
<strong>Lymphocyte Absolute Count [In Blood - Quantitative]</strong>

<img src="charts/b6e1c148-73de-48d6-ad3e-469add392171.png" alt="Lymphocyte Absolute Count [in Blood - Quantitative]" style="width: 450px; height: 225px; page-break-inside: avoid;" />

<p class="conclusion conclusion-positive">Lymphocyte counts stable, comfortably normal</p>

<div class="chart-summary"><p><strong>Description</strong></p>
<p>Peripheral blood absolute lymphocyte count</p>
<p><strong>Measurements</strong></p>
<p>Trend: Flat - stable within normal range</p>
<ul>
<li>May 2024: 1.5 ×10^9/L</li>
<li>Jul 2024: 1.94 ×10^9/L</li>
<li>Sep 2024: 1.5 ×10^9/L</li>
<li>Oct 2024: 1.8 ×10^9/L</li>
<li>Nov 2024: 1.7 ×10^9/L</li>
<li>Dec 2024: 1.5 ×10^9/L</li>
<li>Feb 2025: 66.8 (different unit)</li>
<li>Mar 2025: avg 1.75 ×10^9/L (2 readings)</li>
<li>May 2025: 1.5 ×10^9/L</li>
<li>Jul 2025: 1.9 ×10^9/L</li>
<li>Aug 2025: 70 (different unit)</li>
<li>Sep 2025: 1.6 ×10^9/L</li>
<li>Oct 2025: 1.5 ×10^9/L</li>
<li>Nov 2025: 1.9 ×10^9/L</li>
</ul>
<p><strong>Clinical meaning</strong></p>
<ul>
<li>Values 1.5–1.9 ×10^9/L sit mid normal range</li>
<li>No lymphopenia or lymphocytosis signals</li>
</ul>
<p><strong>Action</strong></p>
<p>No action required</p>
<p><strong>Sample source</strong></p>
<p>Blood</p></div>

</div>

<div class="page-break"></div>

<div class="chart-block">
<a id="chart-5e36d8b9-62d5-4dfc-bdf6-a95d3fc39a9d"></a>
<strong>Red Cell Distribution Width [In Blood - Quantitative]</strong>

<img src="charts/5e36d8b9-62d5-4dfc-bdf6-a95d3fc39a9d.png" alt="Red Cell Distribution Width [in Blood - Quantitative]" style="width: 450px; height: 225px; page-break-inside: avoid;" />

<p class="conclusion conclusion-positive">RDW persistently within reference; transient March variation not clinically significant.</p>

<div class="chart-summary"><p><strong>Description</strong></p>
<p>Red cell size variability index.</p>
<p><strong>Measurements</strong></p>
<p>Trend: Flat - stable values; March 2025 spike likely assay variant</p>
<ul>
<li>Apr 2024: 13.8 %</li>
<li>May 2024: 13.6 %</li>
<li>Sep 2024: 12.7 %</li>
<li>Oct 2024: 12.9 %</li>
<li>Nov 2024: 13.2 %</li>
<li>Dec 2024: 13.1 %</li>
<li>Mar 2025: avg 31.4 % (4 readings)</li>
<li>May 2025: 13.4 %</li>
<li>Jun 2025: 13.7 %</li>
<li>Sep 2025: 13.3 %</li>
<li>Oct 2025: 13.0 %</li>
<li>Nov 2025: 13.5 %</li>
</ul>
<p><strong>Clinical meaning</strong></p>
<ul>
<li>Uniform red cell size; no anisocytosis concern</li>
<li>Low likelihood current iron, B12, folate imbalance</li>
</ul>
<p><strong>Action</strong></p>
<p>No action required.</p>
<p><strong>Sample source</strong></p>
<p>Blood</p></div>

</div>

<div class="page-break"></div>

<div class="chart-block">
<a id="chart-8d7c03d6-664b-485b-b73c-714c5ca2cfa5"></a>
<strong>Eosinophil Percentage [In Blood - Quantitative]</strong>

<img src="charts/8d7c03d6-664b-485b-b73c-714c5ca2cfa5.png" alt="Eosinophil Percentage [in Blood - Quantitative]" style="width: 450px; height: 225px; page-break-inside: avoid;" />

<p class="conclusion conclusion-neutral">Values normal and stable; isolated past spike warrants brief chart review.</p>

<div class="chart-summary"><p><strong>Description</strong></p>
<p>Differential white-cell fraction indicating allergic or parasitic activity</p>
<p><strong>Measurements</strong></p>
<p>Trend: Flat - January 2025 spike resolved; values stable, normal range</p>
<ul>
<li>Apr 2024: 0.5 %</li>
<li>May 2024: 2.0 %</li>
<li>Sep 2024: 1.6 %</li>
<li>Oct 2024: 2.0 %</li>
<li>Dec 2024: 1.7 %</li>
<li>Jan 2025: 36.8 %</li>
<li>Mar 2025: avg 1.5 % (2 readings)</li>
<li>May 2025: avg 0.8 % (2 readings)</li>
<li>Jun 2025: avg 1.1 % (2 readings)</li>
<li>Jul 2025: 2.6 %</li>
<li>Sep 2025: 2.0 %</li>
<li>Oct 2025: 1.9 %</li>
<li>Nov 2025: 1.8 %</li>
</ul>
<p><strong>Clinical meaning</strong></p>
<ul>
<li>Current levels normal, no sustained eosinophilia</li>
<li>Single extreme value suggests isolated event (possible acute allergy, lab error)</li>
</ul>
<p><strong>Action</strong></p>
<p>Review January 2025 eosinophilia episode for context; no intervention needed now.</p>
<p><strong>Sample source</strong></p>
<p>Blood</p></div>

</div>

<div class="page-break"></div>

<a id="cat-cardiovascular"></a>

## Cardiovascular

<div class="category-patterns">
<div class="pattern-card">
<div class="pattern-header">
<h3 class="pattern-title pattern-title-neutral">Borderline Elevated Blood Pressure</h3>
</div>
<div class="pattern-body">
<p class="pattern-description">Both Systolic Blood Pressure and Diastolic Blood Pressure sit just above optimal ranges, indicating <strong>borderline pre-hypertension</strong> that could progress if unaddressed.</p>
<div class="pattern-section">
<div class="pattern-section-title">Connected Charts</div>
<div class="pattern-charts">
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-1931b4e7-5f08-4619-8727-d832b70b7014">Systolic Blood Pressure</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-506b12d1-0a67-49b1-97a7-7c5dffb4f7e1">Diastolic Blood Pressure</a></span>
</div>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Causes</div>
<ul>
<li>High sodium intake</li>
<li>Early essential hypertension</li>
<li>Stress or sympathetic overactivity</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Effects</div>
<ul>
<li>Progression to sustained hypertension</li>
<li>Increased cardiovascular strain</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Possible Actions</div>
<ul>
<li>Initiate home blood-pressure monitoring</li>
<li>Counsel on dietary sodium reduction and weight management</li>
<li>Reassess in 3–6 months or sooner if symptoms develop</li>
</ul>
</div>
</div>
</div>
<div class="pattern-card">
<div class="pattern-header">
<h3 class="pattern-title pattern-title-neutral">Bradycardia with Borderline Hypertension</h3>
</div>
<div class="pattern-body">
<p class="pattern-description">A low Pulse Rate coexists with mildly elevated blood pressures, a combination that may reflect <strong>autonomic imbalance or medication-related bradycardia masking hypertension</strong>.</p>
<div class="pattern-section">
<div class="pattern-section-title">Connected Charts</div>
<div class="pattern-charts">
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-3ee16365-2ef7-44f9-b27c-95d88d6539bd">Pulse Rate</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-1931b4e7-5f08-4619-8727-d832b70b7014">Systolic Blood Pressure</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-506b12d1-0a67-49b1-97a7-7c5dffb4f7e1">Diastolic Blood Pressure</a></span>
</div>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Causes</div>
<ul>
<li>Beta-blocker or calcium-channel blocker use</li>
<li>High aerobic fitness with rising vascular resistance</li>
<li>Thyroid dysfunction affecting heart rate</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Effects</div>
<ul>
<li>Syncope or dizziness from low heart rate</li>
<li>Under-recognized hypertension progressing unchecked</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Possible Actions</div>
<ul>
<li>Review medication list and dosing</li>
<li>Order ECG/Holter to assess conduction system</li>
<li>Screen thyroid function and reassess cardiovascular risk</li>
</ul>
</div>
</div>
</div>
<div class="healthy-patterns-section">
<h4 class="healthy-patterns-header">Healthy Patterns</h4>
<div class="pattern-card">
<div class="pattern-header">
<h3 class="pattern-title pattern-title-healthy">Normal Pulse Pressure</h3>
</div>
<div class="pattern-body">
<p class="pattern-description">The difference between systolic and diastolic values yields a pulse pressure within the typical 30–50 mmHg range, suggesting <strong>preserved arterial compliance</strong>.</p>
<div class="pattern-section">
<div class="pattern-section-title">Connected Charts</div>
<div class="pattern-charts">
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-1931b4e7-5f08-4619-8727-d832b70b7014">Systolic Blood Pressure</a></span>
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-506b12d1-0a67-49b1-97a7-7c5dffb4f7e1">Diastolic Blood Pressure</a></span>
</div>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Causes</div>
<ul>
<li>Adequate vascular elasticity</li>
<li>Absence of significant arterial stiffness</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Effects</div>
<ul>
<li>Lower risk of isolated systolic hypertension</li>
<li>Supports efficient coronary perfusion</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Possible Actions</div>
<ul>
<li>Maintain regular aerobic exercise</li>
<li>Continue monitoring to ensure pressures remain in healthy ranges</li>
</ul>
</div>
</div>
</div>
</div>
</div>

<div class="page-break"></div>

<a id="cat-cardiovascular-charts"></a>

<div class="chart-block">
<a id="chart-1931b4e7-5f08-4619-8727-d832b70b7014"></a>
<strong>Systolic Blood Pressure</strong>

<img src="charts/1931b4e7-5f08-4619-8727-d832b70b7014.png" alt="Systolic Blood Pressure [Quantitative]" style="width: 450px; height: 225px; page-break-inside: avoid;" />

<p class="conclusion conclusion-positive">Systolic pressure consistently normal, stable; spurious low values appear erroneous.</p>

<div class="chart-summary"><p><strong>Description</strong></p>
<p>Arterial pressure during cardiac contraction</p>
<p><strong>Measurements</strong></p>
<p>Trend: Flat - monthly averages steady near 120 mmHg</p>
<ul>
<li>Jul 2024: avg 120 mmHg (7 readings)</li>
<li>Nov 2024: avg 119 mmHg (20 readings)</li>
<li>Feb 2025: 0 mmHg (2 readings; implausible)</li>
<li>Jun 2025: 80 mmHg (1 reading; unit unclear)</li>
<li>Aug 2025: 91 % (1 reading; unit unclear)</li>
<li>Sep 2025: avg 120 mmHg (25 readings)</li>
</ul>
<p><strong>Clinical meaning</strong></p>
<ul>
<li>Typical systolic range 110-130 mmHg maintained</li>
<li>No progressive rise; isolated outliers likely measurement errors</li>
</ul>
<p><strong>Action</strong></p>
<p>No action required</p>
<p><strong>Sample source</strong></p>
<p>Unknown</p></div>

</div>

<div class="page-break"></div>

<div class="chart-block">
<a id="chart-3ee16365-2ef7-44f9-b27c-95d88d6539bd"></a>
<strong>Pulse Rate</strong>

<img src="charts/3ee16365-2ef7-44f9-b27c-95d88d6539bd.png" alt="Pulse Rate [Quantitative]" style="width: 450px; height: 225px; page-break-inside: avoid;" />

<p class="conclusion conclusion-positive">Pulse stable within normal range; single transient tachycardia resolved.</p>

<div class="chart-summary"><p><strong>Description</strong></p>
<p>Beat frequency of cardiac cycles per minute, indicator of autonomic tone and cardiovascular workload</p>
<p><strong>Measurements</strong></p>
<p>Trend: Flat - July 2024 tachycardia spike resolved, values near 70 bpm thereafter</p>
<ul>
<li>Apr 2024: 69 bpm</li>
<li>Jul 2024: avg 114 bpm (2 readings)</li>
<li>Nov 2024: avg 71 bpm (14 readings)</li>
<li>Sep 2025: avg 70 bpm (21 readings)</li>
</ul>
<p><strong>Clinical meaning</strong></p>
<ul>
<li>Most readings 60-100 bpm: physiologic resting range</li>
<li>Isolated July tachycardia may reflect transient stress, activity, or arrhythmia episode</li>
</ul>
<p><strong>Action</strong></p>
<p>Review July tachycardia episode if symptoms present</p>
<p><strong>Sample source</strong></p>
<p>Unknown</p></div>

</div>

<div class="page-break"></div>

<div class="chart-block">
<a id="chart-3ee16365-2ef7-44f9-b27c-95d88d6539bd"></a>
<strong>Pulse Rate</strong>

<img src="charts/3ee16365-2ef7-44f9-b27c-95d88d6539bd.png" alt="Pulse Rate [Quantitative]" style="width: 450px; height: 225px; page-break-inside: avoid;" />

<p class="conclusion conclusion-positive">Pulse stable within normal range; single transient tachycardia resolved.</p>

<div class="chart-summary"><p><strong>Description</strong></p>
<p>Beat frequency of cardiac cycles per minute, indicator of autonomic tone and cardiovascular workload</p>
<p><strong>Measurements</strong></p>
<p>Trend: Flat - July 2024 tachycardia spike resolved, values near 70 bpm thereafter</p>
<ul>
<li>Apr 2024: 69 bpm</li>
<li>Jul 2024: avg 114 bpm (2 readings)</li>
<li>Nov 2024: avg 71 bpm (14 readings)</li>
<li>Sep 2025: avg 70 bpm (21 readings)</li>
</ul>
<p><strong>Clinical meaning</strong></p>
<ul>
<li>Most readings 60-100 bpm: physiologic resting range</li>
<li>Isolated July tachycardia may reflect transient stress, activity, or arrhythmia episode</li>
</ul>
<p><strong>Action</strong></p>
<p>Review July tachycardia episode if symptoms present</p>
<p><strong>Sample source</strong></p>
<p>Unknown</p></div>

</div>

<div class="page-break"></div>

<div class="chart-block">
<a id="chart-506b12d1-0a67-49b1-97a7-7c5dffb4f7e1"></a>
<strong>Diastolic Blood Pressure</strong>

<img src="charts/506b12d1-0a67-49b1-97a7-7c5dffb4f7e1.png" alt="Diastolic Blood Pressure [Quantitative]" style="width: 450px; height: 225px; page-break-inside: avoid;" />

<p class="conclusion conclusion-positive">Diastolic pressure mid-normal, slight early rise then stable; no intervention indicated.</p>

<div class="chart-summary"><p><strong>Description</strong></p>
<p>Arterial pressure during cardiac relaxation</p>
<p><strong>Measurements</strong></p>
<p>Trend: Rising slightly - modest increase since Jul 2024, stabilised by Sep 2025</p>
<ul>
<li>Jul 2024: avg 72 mmHg (6 readings)</li>
<li>Nov 2024: avg 76 mmHg (18 readings)</li>
<li>Sep 2025: avg 76 mmHg (20 readings)</li>
</ul>
<p><strong>Clinical meaning</strong></p>
<ul>
<li>Average values within normal 60-80 mmHg range</li>
<li>Minor upward drift, occasional borderline highs, no sustained elevation</li>
</ul>
<p><strong>Action</strong></p>
<p>No action required</p>
<p><strong>Sample source</strong></p>
<p>Unknown</p></div>

</div>

<div class="page-break"></div>

<a id="cat-other-not-categorisable"></a>

## Other/Not categorisable

<div class="category-patterns">
<div class="pattern-card">
<div class="pattern-header">
<h3 class="pattern-title pattern-title-neutral">Hemoglobin A1c at upper-normal edge for age</h3>
</div>
<div class="pattern-body">
<p class="pattern-description">Hemoglobin A1c is just 0.1 % below the pre-diabetes cut-off, and when considered with the patient’s OMICm Age of 54, <strong>this suggests early insulin-resistance risk that warrants monitoring</strong>.</p>
<div class="pattern-section">
<div class="pattern-section-title">Connected Charts</div>
<div class="pattern-charts">
<span class="toc-pill toc-pill-negative"><span class="pill-icon">📊</span><a href="#chart-67cd9fc2-def8-43ed-9aac-f727967a8161">Hemoglobin A1C [In Blood - Quantitative]</a></span>
<span class="toc-pill toc-pill-neutral"><span class="pill-icon">📊</span><a href="#chart-79ab4e7c-3afb-40df-a48f-e50e3cfc5e04">Omicm Age</a></span>
</div>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Causes</div>
<ul>
<li>Diet high in refined carbohydrates</li>
<li>Sedentary lifestyle</li>
<li>Age-related decline in insulin sensitivity</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Effects</div>
<ul>
<li>Progression to prediabetes or type 2 diabetes</li>
<li>Microvascular changes over time</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Possible Actions</div>
<ul>
<li>Implement or reinforce diet and exercise plan</li>
<li>Re-check Hemoglobin A1c in 6–12 months</li>
<li>Consider fasting glucose or OGTT if additional risk factors present</li>
</ul>
</div>
</div>
</div>
<div class="healthy-patterns-section">
<h4 class="healthy-patterns-header">Healthy Patterns</h4>
<div class="pattern-card">
<div class="pattern-header">
<h3 class="pattern-title pattern-title-healthy">Mid-normal Alkaline Phosphatase with acceptable glycaemic control</h3>
</div>
<div class="pattern-body">
<p class="pattern-description">Alkaline Phosphatase sits comfortably mid-range while Hemoglobin A1c remains below the diabetic threshold, <strong>indicating preserved liver/biliary and bone turnover with no current metabolic stress signals</strong>.</p>
<div class="pattern-section">
<div class="pattern-section-title">Connected Charts</div>
<div class="pattern-charts">
<span class="toc-pill toc-pill-positive"><span class="pill-icon">📊</span><a href="#chart-fbf25ee8-ac60-4416-9c29-615fcbf38fcd">Alkaline Phosphatase [In Serum - Quantitative]</a></span>
<span class="toc-pill toc-pill-negative"><span class="pill-icon">📊</span><a href="#chart-67cd9fc2-def8-43ed-9aac-f727967a8161">Hemoglobin A1C [In Blood - Quantitative]</a></span>
</div>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Causes</div>
<ul>
<li>Adequate nutrient status</li>
<li>Effective glycaemic regulation</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Potential Effects</div>
<ul>
<li>Supports healthy bone remodeling and hepatobiliary function</li>
</ul>
</div>
<div class="pattern-section">
<div class="pattern-section-title">Possible Actions</div>
<ul>
<li>Maintain current lifestyle habits</li>
<li>Routine annual monitoring</li>
</ul>
</div>
</div>
</div>
</div>
</div>

<div class="page-break"></div>

<a id="cat-other-not-categorisable-charts"></a>

<div class="chart-block">
<a id="chart-79ab4e7c-3afb-40df-a48f-e50e3cfc5e04"></a>
<strong>Omicm Age</strong>

<img src="charts/79ab4e7c-3afb-40df-a48f-e50e3cfc5e04.png" alt="OMICm Age [Quantitative]" style="width: 450px; height: 225px; page-break-inside: avoid;" />

<p class="conclusion conclusion-neutral">Biological age improving but remains elevated; further intervention warranted</p>

<div class="chart-summary"><p><strong>Description</strong></p>
<p>Multi-omic biological age estimate reflecting systemic aging rate</p>
<p><strong>Measurements</strong></p>
<p>Trend: Falling – biological age dropped ~6 years over 20 months</p>
<ul>
<li>Jan 2024: 60.3 y</li>
<li>Feb 2024: 59.02 y</li>
<li>Mar 2024: 59.0 y</li>
<li>Dec 2024: 60.3 y</li>
<li>Jan 2025: avg 56.2 y (3)</li>
<li>Feb 2025: avg 59.1 y (3)</li>
<li>Mar 2025: avg 56.7 y (3)</li>
<li>May 2025: 57.9 y</li>
<li>Jun 2025: avg 57.9 y (2)</li>
<li>Aug 2025: 54.0 y</li>
<li>Sep 2025: 54.0 y</li>
</ul>
<p><strong>Clinical meaning</strong></p>
<ul>
<li>Most readings above 54.2 y threshold signal biologic age older than desired</li>
<li>Downward trend indicates partial slowdown of aging processes</li>
</ul>
<p><strong>Action</strong></p>
<p>Discuss with preventive medicine specialist</p>
<p><strong>Sample source</strong></p>
<p>Unknown</p></div>

</div>

<div class="page-break"></div>

<div class="chart-block">
<a id="chart-fbf25ee8-ac60-4416-9c29-615fcbf38fcd"></a>
<strong>Alkaline Phosphatase [In Serum - Quantitative]</strong>

<img src="charts/fbf25ee8-ac60-4416-9c29-615fcbf38fcd.png" alt="Alkaline Phosphatase [in Serum - Quantitative]" style="width: 450px; height: 225px; page-break-inside: avoid;" />

<p class="conclusion conclusion-positive">ALP consistently normal, no concerning trend.</p>

<div class="chart-summary"><p><strong>Description</strong></p>
<p>Serum enzyme reflecting liver bile flow, bone turnover</p>
<p><strong>Measurements</strong></p>
<p>Trend: Flat - stable normal range</p>
<ul>
<li>Apr 2024: 65 U/L</li>
<li>May 2024: 65 U/L</li>
<li>Oct 2024: avg 71 U/L (2 readings)</li>
<li>Nov 2024: avg 69 U/L (2 readings)</li>
<li>Dec 2024: avg 70 U/L (2 readings)</li>
<li>Mar 2025: avg 60 U/L (2 readings)</li>
<li>Jun 2025: 64 U/L</li>
<li>Jul 2025: 58 U/L</li>
<li>Sep 2025: 69 U/L</li>
<li>Oct 2025: 71 U/L</li>
<li>Nov 2025: 54 U/L</li>
</ul>
<p><strong>Clinical meaning</strong></p>
<ul>
<li>All values within stated reference intervals</li>
<li>No biochemical signal for cholestasis or high bone turnover</li>
</ul>
<p><strong>Action</strong></p>
<p>No action required</p>
<p><strong>Sample source</strong></p>
<p>Blood</p></div>

</div>

<div class="page-break"></div>

<div class="chart-block">
<a id="chart-67cd9fc2-def8-43ed-9aac-f727967a8161"></a>
<strong>Hemoglobin A1C [In Blood - Quantitative]</strong>

<img src="charts/67cd9fc2-def8-43ed-9aac-f727967a8161.png" alt="Hemoglobin A1c [in Blood - Quantitative]" style="width: 450px; height: 225px; page-break-inside: avoid;" />

<p class="conclusion conclusion-negative">Core values normal-borderline but large inconsistent outliers warrant immediate verification.</p>

<div class="chart-summary"><p><strong>Description</strong></p>
<p>Glycated hemoglobin reflecting 2–3-month average blood glucose</p>
<p><strong>Measurements</strong></p>
<p>Trend: Flat – Most readings mid-5%; occasional extreme outliers</p>
<ul>
<li>Jul 2024: avg 5.5% (2 readings)</li>
<li>Oct 2024: 5.5%</li>
<li>Feb 2025: 0</li>
<li>Mar 2025: avg 20.7% (3 readings)</li>
<li>Jun 2025: 53.0%</li>
<li>Aug 2025: 41.0%</li>
<li>Oct 2025: avg 4.7% (2 readings)</li>
<li>Nov 2025: avg 5.8% (2 readings)</li>
</ul>
<p><strong>Clinical meaning</strong></p>
<ul>
<li>Mid-5% values suggest normoglycemia to borderline prediabetes</li>
<li>Extreme mismatched values indicate possible unit or assay variation</li>
</ul>
<p><strong>Action</strong></p>
<p>Confirm assay units, repeat HbA1c to validate glycemic status.</p>
<p><strong>Sample source</strong></p>
<p>Blood</p></div>

</div>

<div class="page-break"></div>

<a id="report-settings"></a>
<div class="settings-section">
<h2>Report Settings</h2>

<h3>Configuration</h3>
<table>
<tbody>
<tr><td><strong>User ID</strong></td><td>38c83383-788f-433b-8683-b6df2bd2fda6</td></tr>
<tr><td><strong>Report ID</strong></td><td>test-chr-001</td></tr>
<tr><td><strong>Filename</strong></td><td>test-report.pdf</td></tr>
<tr><td><strong>Version</strong></td><td>1.0.0</td></tr>
<tr><td><strong>Model</strong></td><td>gpt-5-mini</td></tr>
<tr><td><strong>Temperature</strong></td><td>0.2</td></tr>
<tr><td><strong>Language</strong></td><td>en</td></tr>
<tr><td><strong>Data Types</strong></td><td>biomarkers,demographics</td></tr>
</tbody>
</table>
<h3>Data Metrics</h3>
<p><strong>Enabled Types:</strong> biomarkers,demographics</p>

<table>
<tbody>
<tr><td><strong>Biomarkers</strong></td><td>7,113 records (3,690 unique)</td></tr>
<tr><td><strong>Date Range</strong></td><td>1999-01-01 to 2025-12-01</td></tr>
</tbody>
</table>

<h3>Processing Metrics</h3>
<table>
<tbody>
<tr><td><strong>Setup Phase</strong></td><td>28ms</td></tr>
<tr><td><strong>Outline Phase</strong></td><td>19.9s</td></tr>
<tr><td><strong>Report Phase</strong></td><td>15.5s</td></tr>
<tr><td><strong>Total Runtime</strong></td><td><strong>35.5s</strong></td></tr>
</tbody>
</table>

</div>